Buy Blitz Triple G 2026 — Triple Agonist (GLP-1/GIP/Glucagon) for Metabolic Receptor Research (EU)

Peptide Research · 28 June 2026 · 12 min read · Research Use Only

In short: Blitz Triple G is a synthetic multi-target research peptide of GLP-1/GIP/Glucagon class (triple agonist). This research guide summarises what the published in-vitro and animal model literature documented for this peptide class – from receptor binding and cAMP response profiles to observations in adipocyte, hepatocyte, and pancreas cell models. At BlitzLab, as 10mg vial with batch-related Certificate of Analysis (COA), HPLC ≥ 99 %, EU delivery. Price: 99.90. For research use only (RUO).

Blitz Triple G at a glance

DesignationBlitz Triple G
IdentitySynthetic multi-target research peptide of the GLP-1/GIP/glucagon class (triple agonist)
SynonymsTriple G, tri-target peptide
Research contextReceptor binding & cAMP response at GLP-1, GIP and glucagon receptors, receptor-pharmacological in-vitro/cell models (in vitro/animal model)
CAS numberSee CoA (the batch-specific COA is authoritative)
Molecular formulaSee CoA
FormLyophilised powder (freeze-dried), sealed vial
Amount10 mg per vial
Purity≥99% (HPLC), identity confirmed by LC-MS
AnalysisExternal third-party laboratory, batch-specific COA
Intended useFor Research Use Only (RUO)
Price99.90 · Shipping from Germany

What is Blitz Triple G?

Blitz Triple G is a synthetic multi-target research peptide the GLP-1/GIP/Glucagon class. As a so-called triple agonist, it belongs to a group of peptides that are being investigated in preclinical literature for three metabolically relevant receptors: the GLP-1 receptor, and GIP receptor and the Glucagon receptor. The substance is supplied as a stable lyophilisate in a sealed vial (10 mg) and is used in laboratory research as a defined reference substance for receptor pharmacology and cell biology study models. The CAS number and molecular formula are documented in the batch-specific certificate of analysis.

Molecular profile & target structure

Triple agonists of this class are designed so that a single peptide sequence binds to three related receptors in the incretin and glucagon families. GLP-1, GIP and glucagon receptors are among the Class B G protein-coupled receptors (GPCRs) and are about the activation of adenylyl cyclase with the cAMP signalling pathway linked. In the research literature, Blitz Triple G therefore serves as a model system for investigating the parallel binding and signal response at multiple metabolic target receptors to characterise. The combination of a defined synthetic sequence and good analytical characterisation makes the peptide a frequently used reference in receptor and metabolic biology study models.

What in-vitro and animal model studies document

The following summary reflects only what is described in the publicly accessible preclinical literature – it is not a statement about an effect or suitability in humans.

These observations stem from in-vitro and animal models. They underpin research interest in triple agonists of the GLP-1/GIP/glucagon class but provide no information about safety, efficacy, or use outside of laboratory research.

Purity, COA & Analytical Testing

Purity and identity are the two values that count. HPLC demonstrates purity (target value ≥ 99 %), LC-MS confirms the identity via molecular mass. Both values are listed on the batch-related COA. We explain how to read such a certificate in Understanding and reading a Certificate of Analysis (COA); the procedures themselves in Peptide Purity: HPLC and LC-MS Explained.

Storage & Handling

As a lyophilised product, Blitz Triple G is stable when stored is kept cool, dry and protected from light and stored – ideally at -20°C for longer storage. Please refer to the COA for batch-specific information. Principles: Storing and Handling Research Peptides.

Buying Blitz Triple G in the EU – what matters

What matters is not the price, but this: Does the label match the contents? Here's what BlitzLab delivers on:

What else to look out for with a reputable provider: 7-point checklist.

Frequently Asked Questions about Buying Blitz Triple G

No. Blitz Triple G is intended for scientific in-vitro laboratory research use only – not for human, animal or medicinal use.
Published in vitro and animal-model studies examine triple agonists for, among other things, receptor binding and cAMP response profiles at GLP-1, GIP, and glucagon receptors, as well as in adipocyte, hepatocyte, and pancreas cell models. This summarises research observations and is not a statement about human application.
Yes. Each batch is tested externally by HPLC and LC-MS; the batch-specific COA is available on the Product page inspectable.
Yes. Shipped in plain packaging from Germany; within the EU delivery usually takes 2–5 working days, with tracking.

Note on Sources & RUO

This guide summarises publicly available preclinical research literature (in vitro and animal models) on triple agonists of the GLP-1/GIP/glucagon class. The enclosed Certificate of Analysis is always authoritative for the identity, CAS number, molecular formula and purity of the batch supplied. All information is for informational purposes in a research context (Research Use Only) only and does not constitute medical advice, dosage, or application recommendations.

Blitz Triple G 10 mg – View batch with COA

Certificate of Analysis, specification, and availability directly on the product page.

To the product